Medtronic Pays $12M To 5 States For Deceptive Marketing Of Infuse Bone Graft
(December 14, 2017, 1:45 PM EST) -- BOSTON — Medtronic Inc. has agreed to pay $12 million to five states to resolve allegations that it engaged in deceptive marketing of the company’s Infuse bone graft, according to a...
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login